טרובלט 100 מ"ג

Country: Iżrael

Lingwa: Ebrajk

Sors: Ministry of Health

Ingredjent attiv:

RETIGABINE 100 MG

Disponibbli minn:

GLAXO SMITH KLINE (ISRAEL) LTD

Kodiċi ATC:

N03AX21

Għamla farmaċewtika:

FILM COATED TABLETS

Rotta amministrattiva:

PER OS

Manifatturat minn:

GLAXO WELLCOME SA, SPAIN

Grupp terapewtiku:

RETIGABINE

Indikazzjonijiet terapewtiċi:

Trobalt is indicated as adjunctive treatment of drug-resistant partial onset seizures with or without secondary generalization in patients aged 18 -65 years with epilepsy, where other appropriate drug combinations have proved inadequate or have not been tolerated.

Data ta 'l-awtorizzazzjoni:

2012-11-01